Summary
September 2007, Vol. 16, No. 9, Pages 1405-1413 , DOI 10.1517/13543784.16.9.1405

HU-331: a cannabinoid quinone, with uncommon cytotoxic properties and low toxicity

Maximilian Peters & Natalya M Kogan
The Hebrew University, Department of Medicinal Chemistry and Natural Products, School of Pharmacy, Jerusalem 91120, Israel +972 2 6758635; +972 2 6758073;
Author for correspondence



The oxidation of cannabis constituents has given rise to their corresponding quinones, which have been identified as cytotoxic agents. Out of these molecules the quinone of cannabidiol – the most abundant non-psychoactive cannabinoid in Cannabis sativa – has shown the highest cytotoxicity. This compound was named HU-331 and it exerts antiangiogenic properties, induces apoptosis to endothelial cells and inhibits topoisomerase II in nanomolar concentrations. Unlike other quinones, it is not cardiotoxic and does not induce the formation of free radicals. A comparative in vivo study in mice has shown HU-331 to be less toxic and more effective than the commonly used doxorubicin. This review summarises the properties of HU-331 and compares it with doxorubicin and other topoisomerase II inhibitors.

Full Text | PDF (141 KB) | PDF Plus (267 KB)
 

Prev. Article | Next Article
View/Print PDF (141 KB)
View PDF Plus (267 KB)
Add to favourite
Email to a friend
TOC Alert | Citation Alert What is RSS?

 
 
Quick Search
for 
Authors:
Maximilian Peters
Natalya M Kogan
Keywords:
antiangiogenesis
apoptosis
cannabinoid
cardiotoxicity
preclinical study
quinone
topoisomerase II